Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Bangkok Genomics Innovation PCL PEG Ratio?
Bangkok Genomics Innovation PCLBKK:BKGI +0.99%45 PEG Ratio is 2.25 as of Jul. 18, 2026, which is 48% above its 10-year median of 1.52. GuruFocus rates BKK:BKGI with a GF Score™ of 45/100. The stock has 12 warning signs investors should review. Among 36 Medical Diagnostics & Research companies, Bangkok Genomics Innovation PCL ranks better than 50% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Bangkok Genomics Innovation PCL's PEG Ratio or its related term are showing as below:
BKK:BKGI'
s PEG Ratio Range Over the Past 10 Years
Min: 1.37 Med: 1.52 Max: 2.34
Current: 2.25
During the past 7 years, Bangkok Genomics Innovation PCL's highest PEG Ratio was 2.34. The lowest was 1.37. And the median was 1.52.
BKK:BKGI's PEG Ratio is ranked better than 50% of 36
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.395
vs BKK:BKGI: 2.25
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Bangkok Genomics Innovation PCL (BKK:BKGI) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Bangkok Genomics Innovation PCL PEG Ratio Related Terms
Bangkok Genomics Innovation PCL PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Bangkok Genomics Innovation PCL's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bangkok Genomics Innovation PCL PEG Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Bangkok Genomics Innovation PCL's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Bangkok Genomics Innovation PCL's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Bangkok Genomics Innovation PCL (BKK:BKGI) has a PEG Ratio of 2.25 as of Jul. 18, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Bangkok Genomics Innovation PCL and its competitors. This is 48% above median its historical median of 1.52. Over the past decade, Bangkok Genomics Innovation PCL's PEG Ratio has ranged from 1.37 to 2.34. According to the industry distribution chart, Bangkok Genomics Innovation PCL ranks #18 out of 36 companies in the Medical Diagnostics & Research industry, placing it in the top 50%.
Is Bangkok Genomics Innovation PCL's PEG Ratio too high?
Bangkok Genomics Innovation PCL's current PEG Ratio of 2.25 is 48% above median its 10-year median of 1.52. Over the past 10 years, this metric has ranged from a low of 1.37 to a high of 2.34. The Medical Diagnostics & Research industry median PEG Ratio is 2.40. Bangkok Genomics Innovation PCL's value of 2.25 is 6.1% below this industry median. Based on the distribution chart, Bangkok Genomics Innovation PCL ranks #18 out of 36 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Bangkok Genomics Innovation PCL has a GF Score™ of 45/100, reflecting its overall financial health beyond just this single metric.
How does Bangkok Genomics Innovation PCL's PEG Ratio compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Bangkok Genomics Innovation PCL ranks #18 out of 36 companies for PEG Ratio. This puts Bangkok Genomics Innovation PCL in the upper half of its industry. The industry median PEG Ratio is 2.40. Bangkok Genomics Innovation PCL's value of 2.25 is 6.1% below this benchmark. Historically, Bangkok Genomics Innovation PCL's own PEG Ratio has ranged from 1.37 to 2.34 over the past decade. While the company's 10-year median is 1.52 vs. the industry median of 2.40, Bangkok Genomics Innovation PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Diagnostics & Research company?
The median PEG Ratio among Medical Diagnostics & Research companies is 2.40, based on 36 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bangkok Genomics Innovation PCL's current PEG Ratio of 2.25 is 6.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Bangkok Genomics Innovation PCL and its competitors. For the Medical Diagnostics & Research industry, the median PEG Ratio is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bangkok Genomics Innovation PCL's current PEG Ratio is 2.25, which is 48% above median its own 10-year median of 1.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bangkok Genomics Innovation PCL stock overvalued right now?
Bangkok Genomics Innovation PCL (BKK:BKGI) has a current PEG Ratio of 2.25. The current PEG Ratio is 2.25, which is 48% above median its 10-year median of 1.52 and 6.1% below the Medical Diagnostics & Research industry median of 2.40. Bangkok Genomics Innovation PCL's overall GF Score™ is 45/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Bangkok Genomics Innovation PCL (BKK:BKGI), the current PEG Ratio is 2.25 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bangkok Genomics Innovation PCL Business Description
Bangkok Genomics Innovation PCL operate a laboratory and provide medical analysis services. Its services includes Screening for genetic abnormalities in reproductive health (Reproductive Health Testing Services),Infectious Disease Analysis Product Group (Infectious - Related Testing Services), Other screening product groups (Other Testing Services), providing technology services (Tech Solution Services), and Sales of other medical products Related (Medical - Related Products). Its segments include Sale of laboratory reagents and related products; Testing and analysis services, which derives maximum revenue; and Sale and advanced therapy medicinal product.
45GF Score
Get the complete analysis for BKK:BKGI
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:BKGI has been successfully added to your 
